The first translational study, which demonstrated that the levels of the inhibitory IL-33 receptor sST2 are increased in human stroke patients, additionally measured ST2 levels in 53 IS patients with a middle cerebral artery non-lacunar stroke during the first 4.5 h of symptom onset. Here, IL1RL1 is linked to stroke disorder.